“Older adults excluded, underrepresented in clinical trials for COVID-19,” by Emma Stefanutti, The Stanford Daily

Quote:

“Older adults are routinely excluded from participating in COVID-19 clinical trials, according to a preliminary study at Harvard Medical School. The Daily interviewed Marina Martin, an assistant professor and section chief of Geriatric Medicine at Stanford Medicine, to learn about the implications of elderly underrepresentation in clinical trials, particularly for a virus that sees 8 of 10 deaths occurring in adults over the ages of 65. … Martin noted that elderly underrepresentation in trials may lead to inaccurate data and additionally worsen crisis conditions for older adults, who are already among the most vulnerable to complications of the virus.”

 

LTC Comment (from Stephen A. Moses, President, Center for Long-Term Care Reform):

Do you start to get the sense that someone’s out to get the old folks?